Key Insights

Highlights

Success Rate

78% trial completion

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 49/100

Termination Rate

7.5%

4 terminated out of 53 trials

Success Rate

77.8%

-8.7% vs benchmark

Late-Stage Pipeline

4%

2 trials in Phase 3/4

Results Transparency

50%

7 of 14 completed with results

Key Signals

7 with results78% success

Data Visualizations

Phase Distribution

39Total
Not Applicable (15)
Early P 1 (5)
P 1 (9)
P 2 (8)
P 3 (2)

Trial Status

Completed14
Recruiting12
Not Yet Recruiting11
Active Not Recruiting5
Terminated4
Enrolling By Invitation3

Trial Success Rate

77.8%

Benchmark: 86.5%

Based on 14 completed trials

Clinical Trials (53)

Showing 20 of 20 trials
NCT07254988Not ApplicableTerminated

Gut Peptides and Bone Remodeling in Children With Neuromuscular Disorders

NCT06839469Recruiting

Establishing Walking-related Digital Biomarkers in Rare Childhood Onset Progressive Neuromuscular Disorders

NCT07347548Phase 1Active Not RecruitingPrimary

A Trial to Investigate the Safety and Pharmacokinetics of GRT6019 in Healthy Male Participants

NCT07332013Not ApplicableRecruitingPrimary

Urinary Titin Biomarker in DMD

NCT07467187Not Yet Recruiting

Invasive Home Ventilation in Denmark

NCT07475754Not ApplicableNot Yet RecruitingPrimary

A Study to Evaluate the Safety and Tolerability of Rituxan in Duchenne Muscular Dystrophy

NCT04322357Phase 2CompletedPrimary

Twice Weekly Steroids and Exercise as Therapy for DMD

NCT07037862Phase 1RecruitingPrimary

A Study in Participants With Duchenne Muscular Dystrophy Amenable to Exon 44 Skipping to Evaluate the Safety and Efficacy of ENTR-601-44

NCT07038824Phase 1RecruitingPrimary

A Study in Participants With Duchenne Muscular Dystrophy Amenable to Exon 45 Skipping to Evaluate the Safety and Efficacy of ENTR-601-45

NCT07435116Enrolling By InvitationPrimary

Duchenne Muscular Dystrophy and the Viscoelastic Properties of Upper Limb Muscles

NCT07437378CompletedPrimary

Relation Between Muscle Architecture and Functional Ability in Children With Duchenne Muscular Dystrophy

NCT07423026Not Yet RecruitingPrimary

A Remote Study Using Technology to Assess Outcomes in DMD

NCT07317063Phase 1CompletedPrimary

A Trial to Investigate Safety and Pharmacokinetics of GRT6019, Including Food Effect, in Healthy Male Participants

NCT07402122Not Yet RecruitingPrimary

Registry for Duchenne and Becker Muscular Dystrophy

NCT07369609Not Yet RecruitingPrimary

Factors Influencing Physical Activity Levels in Children With Duchenne Muscular Dystrophy: An ICF-CY-Based Study

NCT07368400Not ApplicableNot Yet RecruitingPrimary

DMD and Gamified Physiotherapy

NCT06887491Not ApplicableEnrolling By InvitationPrimary

The Effect of Dual-tasking Program on Cognitive and Physical Functions and Independence in Activities of Daily Living in Children With Duchenne Muscular Dystrophy: A Single-blind Randomized Controlled Trial

NCT07356063Not ApplicableNot Yet RecruitingPrimary

Self-Efficacy Enhancement Using a Multicomponent Support Group for Caregivers of Children With DMD/SMA

NCT07282652Early Phase 1Active Not RecruitingPrimary

A Study to Evaluate the Safety and Tolerability of RAG-18 in Pediatric Patients With Duchenne Muscular Dystrophy

NCT07338812Not ApplicableCompletedPrimary

Virtual Reality and Whole Body Vibration on Muscle Strength and Balance in Children With DMD

Scroll to load more

Research Network

Activity Timeline